查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1859740

全球个人化神经认知评估工具市场预测（至2032年）：按类型、部署类型、认知功能、技术、操作模式、最终用户和地区分類的分析

Personalized Neurocognitive Assessment Tools Market Forecasts to 2032 - Global Analysis By Type, Deployment Type, Cognitive Functionality, Technology, Mode of Administration, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球个人化神经认知评估工具市场预计到 2025 年将达到 162.9 亿美元，到 2032 年将达到 290.2 亿美元，预测期内复合年增长率为 8.6%。

个人化神经认知评估工具是专门设计的系统，用于评估个人的认知能力，包括记忆力、注意力、问题解决能力和处理速度，并根据其具体需求进行客製化。这些工具利用数位技术、自适应测试和分析，提供精准的个人化见解。它们有助于及早发现认知障碍，追踪认知能力随时间的变化，并为临床、教育和专业领域的干预措施提供资讯。透过提供针对每个人需求量身定制的认知概况，这些工具能够帮助优化策略、提升表现并改善心理健康。

神经系统疾病盛行率不断上升

阿兹海默症、帕金森氏症和多发性硬化症等神经系统疾病在全球范围内的日益流行，推动了对个人化神经认知评估工具的需求。这些工具能够实现认知衰退的早期诊断和持续监测，使临床医生能够制定个人化的治疗方案。随着人口老化和神经退化性疾病的日益普遍，数位化认知评估技术的应用正在加速。人工智慧主导的分析和云端基础的神经认知平台正在提高诊断的准确性和扩充性。医疗机构和科技公司之间不断扩大的研究合作，正在进一步推动神经评估解决方案的创新。

资料隐私和安全问题

遵守 HIPAA 和 GDPR 等全球标准需要强大的加密和网路安全框架，这增加了营运的复杂性。未授权存取、资料外洩和使用者信任度不足会阻碍大规模应用，尤其是在云端基础的系统中。企业面临着平衡可及性和保密性的挑战，尤其是在远距和远距神经心理学领域。区块链和边缘运算等新技术正在被研究以提高透明度和资料完整性。然而，监管的不确定性和不断上涨的网路安全成本仍然是市场扩张的主要限制因素。

非临床应用

职场、教育和消费者健康计画正在利用这项技术进行早期认知筛检、压力评估和心理表现优化。人工智慧驱动的自我评估应用程式和游戏化的神经认知训练工具正受到越来越多希望主动管理大脑健康的人的青睐。企业健康倡议和学术绩效计划正在引入神经认知分析，以提升情绪智商和专注力。行动技术和物联网感测器的进步使得在临床环境之外进行远端、便捷的评估成为可能。随着人们对认知健康的认识不断提高，预计非临床应用将在各行各业显着扩展。

与传统方法竞争

许多医疗专业人员由于担心结果的标准化和可比性，对全面采用数位化系统持谨慎态度。在许多诊断环境中，传统的纸笔或面对面方法仍然被视为黄金标准。此外，报销机制通常更倾向于传统评估方式，限制了数位化替代方案的商业性应用。为了克服这一挑战，市场相关人员正在转向混合模式，将数位资料洞察与传统评估框架相结合。

新冠疫情的影响：

远端医疗平台和远距监测工具迅速普及，使临床医生能够继续以虚拟方式评估认知功能。人工智慧主导的演算法和云端基础的仪錶板在疫情封锁期间支援了大规模数据收集和远端分析。然而，设备製造早期中断以及医疗设施的有限使用延缓了部分地区的普及。疫情也凸显了心理健康和认知韧性的重要性，促使人们对数位脑健康解决方案进行长期投资。即使在疫情结束后，混合式和远端检测预计仍将是提供个人化神经认知护理的关键。

预计在预测期内，云端基础的细分市场将占据最大份额。

由于其扩充性、远端存取和即时分析能力，预计在预测期内，云端基础市场将占据最大的市场份额。云端基础设施能够无缝整合来自多个来源的神经认知数据，包括行动应用、穿戴式装置和临床系统。人们对远端评估和数位健康平台的日益偏好，进一步推动了对云端基础的工具的需求。主要企业正致力于加强资料安全性和与电子病历系统的互通性，以促进临床应用。

预计在预测期内，医药产业将以最高的复合年增长率成长。

由于神经认知评估工具在药物研发和临床试验中的应用日益广泛，製药业在预测期内预计将呈现最高的成长率。这些工具被用于评估认知副作用、监测患者反应并支持精准医疗倡议。将数位生物标记与人工智慧主导的认知分析结合，能够帮助製药公司优化治疗效果和安全性。数位医疗新兴企业与製药公司之间日益密切的合作正在推动技术创新。源自数位评估的认知终点正逐渐被监管机构接受，进一步促进其融入开发平臺。

占比最大的地区：

在预测期内，亚太地区预计将占据最大的市场份额，这主要得益于医疗基础设施的不断完善、人们对认知健康的日益关注以及政府对数位医疗投入的不断增加。中国、日本、韩国和印度等国家正在采用基于人工智慧的神经认知评估平台，用于临床和研究用途。智慧型手机普及率的提高和云端技术的广泛应用，使得都市区和农村人口更容易获得数位脑健康工具。学术机构与技术提供者之间的合作正在加速认知分析和心理健康领域的创新。该地区的新兴企业正在开发本地化的、特定语言的认知测试，以提高整体性和准确性。

复合年增长率最高的地区：

预计北美地区在预测期内将实现最高的复合年增长率，这主要得益于其先进的医疗保健体系、强劲的研发投入以及早期的技术应用。美国在将人工智慧、机器学习和神经资讯学整合到认知评估平台方面处于领先地位。有利的报销机制和政府推动心理健康数位化的措施进一步促进了市场成长。主要企业正致力于互通性、获得FDA核准以及进行临床检验，以扩大市场渗透率。此外，该地区还受益于强大的学术研究中心和数位健康新兴企业网络，这些都极大地推动了创新。

免费客製化服务：

订阅本报告的用户可享有以下免费客製化服务之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 原始研究资料
    • 次级研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球个人化神经认知评估工具市场（按类型划分）

  • 电脑化认知评估工具
    • 网路为基础的平台
    • 基于应用程式的平台
  • 传统的纸笔评估工具
  • 其他类型

6. 全球个人化神经认知评估工具市场（依部署类型划分）

  • 本地部署
  • 云端基础的

7. 全球个人化神经认知评估工具市场（依认知功能划分）

  • 记忆
  • 笔记
  • 执行功能
  • 语言技能
  • 处理速度
  • 视觉空间能力

8. 全球个人化神经认知评估工具市场（依技术划分）

  • 人工智慧 (AI) 工具
  • 虚拟实境（VR）/扩增实境（AR）工具
  • 云端基础的平台
  • 行动应用

9. 全球个人化神经认知评估工具市场（依操作类型划分）

  • 自我管理
  • 由医生操作

10. 全球个人化神经认知评估工具市场（依最终用户划分）

  • 医院和诊所
  • 研究和学术机构
  • 家庭医疗保健
  • 诊断中心
  • 其他最终用户

11. 全球个人化神经认知评估工具市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与併购
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十三章：企业概况

  • Cambridge Cognition Ltd.
  • SCHUHFRIED GmbH
  • Cogstate Ltd.
  • Constant Therapy Health
  • CogniFit Inc.
  • NeuronUp
  • BrainCheck, Inc.
  • Creyos
  • Neurotrack Technologies
  • CNS Vital Signs, LLC
  • Pearson Clinical
  • Lumosity
  • Akili Interactive Labs
  • Neurocog Trials, Inc.
  • Posit Science
Product Code: SMRC31964

According to Stratistics MRC, the Global Personalized Neurocognitive Assessment Tools Market is accounted for $16.29 billion in 2025 and is expected to reach $29.02 billion by 2032 growing at a CAGR of 8.6% during the forecast period. Personalized Neurocognitive Assessment Tools are specialized systems that evaluate a person's cognitive abilities, such as memory, focus, problem-solving, and processing speed, customized to their specific requirements. Utilizing digital technologies, adaptive tests, and analytics, they deliver accurate, individualized insights. These tools assist in early identification of cognitive challenges, track changes over time, and inform interventions across clinical, educational, and professional contexts. By providing tailored cognitive profiles, they help optimize strategies, enhance performance, and improve mental health outcomes.

Market Dynamics:

Driver:

Rising prevalence of neurological disorders

The increasing global incidence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis is fueling the demand for Personalized Neurocognitive Assessment Tools. These tools enable early diagnosis and continuous monitoring of cognitive decline, empowering clinicians to deliver individualized treatment plans. As populations age and neurodegenerative conditions become more common, the adoption of digital cognitive assessment technologies is accelerating. AI-driven analytics and cloud-based neurocognitive platforms are enhancing diagnostic accuracy and scalability. Growing research collaborations between healthcare institutions and technology companies are further advancing innovation in neuro-assessment solutions.

Restraint:

Data privacy and security concerns

Compliance with global standards such as HIPAA and GDPR demands robust encryption and cybersecurity frameworks, increasing operational complexity. Unauthorized access, data breaches, and lack of user trust can hinder large-scale adoption, especially in cloud-based systems. Companies face challenges in balancing accessibility with confidentiality, particularly in remote and tele-neuropsychology settings. Emerging technologies like blockchain and edge computing are being explored to enhance transparency and data integrity. However, regulatory uncertainties and rising cybersecurity costs continue to act as key restraints for market expansion.

Opportunity:

Adoption in non-clinical settings

The workplaces, educational institutions, and consumer wellness programs are being leveraged for early cognitive screening, stress assessment, and mental performance optimization. AI-powered self-assessment apps and gamified neurocognitive training tools are gaining traction among individuals seeking proactive brain health management. Corporate wellness initiatives and academic performance enhancement programs are incorporating neurocognitive analytics to promote emotional intelligence and focus. Advances in mobile technology and IoT-enabled sensors are supporting remote, user-friendly assessments beyond clinical boundaries. As awareness of cognitive well-being rises, non-clinical adoption is expected to expand significantly across industries.

Threat:

Competition from traditional methods

Many healthcare professionals remain hesitant to transition to fully digital systems, citing concerns over standardization and result comparability. Traditional pen-and-paper or in-person methods are still considered the gold standard in many diagnostic settings. Furthermore, reimbursement structures often favor conventional assessments, limiting the commercial uptake of digital alternatives. To overcome this challenge, market players are focusing on hybrid models that combine digital data insights with traditional evaluation frameworks.

Covid-19 Impact:

Telehealth platforms and remote monitoring tools gained rapid adoption, enabling clinicians to continue assessing cognitive function virtually. AI-driven algorithms and cloud-based dashboards supported large-scale data collection and remote analytics during lockdowns. However, initial disruptions in device manufacturing and limited access to healthcare facilities slowed adoption in certain regions. The pandemic also underscored the importance of mental health and cognitive resilience, driving long-term investment in digital brain health solutions. Post-pandemic, hybrid and remote testing modalities are expected to remain integral to personalized neurocognitive care delivery.

The cloud-based segment is expected to be the largest during the forecast period

The cloud-based segment is expected to account for the largest market share during the forecast period, driven by its scalability, remote accessibility, and real-time analytics capabilities. Cloud infrastructure allows seamless integration of neurocognitive data from multiple sources, including mobile apps, wearables, and clinical systems. The rising preference for tele-assessment and digital health platforms is further accelerating demand for cloud-based tools. Key players are focusing on enhancing data security and interoperability with EHR systems to strengthen clinical adoption.

The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceutical companies segment is predicted to witness the highest growth rate, due to the rising adoption of neurocognitive assessment tools in drug discovery and clinical trials. These tools are being used to evaluate cognitive side effects, monitor patient responses, and support precision medicine initiatives. Integration of digital biomarkers and AI-driven cognitive analytics enables pharmaceutical firms to optimize treatment efficacy and safety. The increasing number of collaborations between digital health startups and pharma companies is boosting technological innovation. Cognitive endpoints derived from digital assessments are gaining regulatory acceptance, further driving integration into R&D pipelines.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by expanding healthcare infrastructure, rising awareness of cognitive health, and growing government investment in digital healthcare. Countries like China, Japan, South Korea, and India are adopting AI-based neurocognitive assessment platforms for both clinical and research applications. Increased smartphone penetration and cloud adoption are making digital brain health tools more accessible across urban and rural populations. Partnerships between academic institutions and technology providers are accelerating innovation in cognitive analytics and mental wellness. Emerging startups in the region are developing localized and language-specific cognitive tests, improving inclusivity and accuracy.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fueled by advanced healthcare systems, strong R&D investment, and early technology adoption. The U.S. leads in integrating AI, machine learning, and neuroinformatics into cognitive assessment platforms. Favorable reimbursement frameworks and government initiatives promoting mental health digitization are further enhancing market growth. Leading companies are focusing on interoperability, FDA approvals, and clinical validation to expand market penetration. The region also benefits from a strong network of academic research centers and digital health startups driving innovation.

Key players in the market

Some of the key players in Personalized Neurocognitive Assessment Tools Market include Cambridge, SCHUHFRIED, Cogstate Ltd, Constant T, CogniFit In, NeuronUp, BrainChec, Creyos, Neurotrac, CNS Vital S, Pearson C, Lumosity, Akili Inter, Neurocog, and Posit Scienc.

Key Developments:

In August 2025, CogniFit announces the release of embeddable brain games giving web developers and product managers a simple, science-backed tool to increase user retention, interaction, and session time across digital platforms. As interactive content becomes a strategic must-have, CogniFit's plug-and-play solutions make it easier than ever to captivate audiences and deliver measurable results.

In October 2024, Medidata announced a partnership with neuroscience solutions leader Cogstate to reshape clinical trials and outcomes measurement for central nervous system (CNS) diseases across neurodegenerative, psychiatric, motor, and rare neurodevelopmental disorders, among others.

Types Covered:

  • Computerized Cognitive Assessment Tools
  • Traditional Paper-and-Pencil Assessment Tools
  • Other Types

Deployment Types Covered:

  • On-premise
  • Cloud-based

Cognitive Functionalities Covered:

  • Memory
  • Attention
  • Executive Function
  • Language Skills
  • Processing Speed
  • Visuospatial Skills

Technologies Covered:

  • Artificial Intelligence (AI) Enabled Tools
  • Virtual Reality (VR) / Augmented Reality (AR) Tools
  • Cloud-Based Platforms
  • Mobile Applications

Mode of Administrations Covered:

  • Self-administered
  • Clinician-administered

End Users Covered:

  • Hospitals & Clinics
  • Research & Academic Institutes
  • Home Healthcare
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Personalized Neurocognitive Assessment Tools Market, By Type

  • 5.1 Introduction
  • 5.2 Computerized Cognitive Assessment Tools
    • 5.2.1 Web-based platforms
    • 5.2.2 App-based platforms
  • 5.3 Traditional Paper-and-Pencil Assessment Tools
  • 5.4 Other Types

6 Global Personalized Neurocognitive Assessment Tools Market, By Deployment Type

  • 6.1 Introduction
  • 6.2 On-premise
  • 6.3 Cloud-based

7 Global Personalized Neurocognitive Assessment Tools Market, By Cognitive Functionality

  • 7.1 Introduction
  • 7.2 Memory
  • 7.3 Attention
  • 7.4 Executive Function
  • 7.5 Language Skills
  • 7.6 Processing Speed
  • 7.7 Visuospatial Skills

8 Global Personalized Neurocognitive Assessment Tools Market, By Technology

  • 8.1 Introduction
  • 8.2 Artificial Intelligence (AI) Enabled Tools
  • 8.3 Virtual Reality (VR) / Augmented Reality (AR) Tools
  • 8.4 Cloud-Based Platforms
  • 8.5 Mobile Applications

9 Global Personalized Neurocognitive Assessment Tools Market, By Mode of Administration

  • 9.1 Introduction
  • 9.2 Self-administered
  • 9.3 Clinician-administered

10 Global Personalized Neurocognitive Assessment Tools Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals & Clinics
  • 10.3 Research & Academic Institutes
  • 10.4 Home Healthcare
  • 10.5 Diagnostic Centers
  • 10.6 Other End Users

11 Global Personalized Neurocognitive Assessment Tools Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Cambridge Cognition Ltd.
  • 13.2 SCHUHFRIED GmbH
  • 13.3 Cogstate Ltd.
  • 13.4 Constant Therapy Health
  • 13.5 CogniFit Inc.
  • 13.6 NeuronUp
  • 13.7 BrainCheck, Inc.
  • 13.8 Creyos
  • 13.9 Neurotrack Technologies
  • 13.10 CNS Vital Signs, LLC
  • 13.11 Pearson Clinical
  • 13.12 Lumosity
  • 13.13 Akili Interactive Labs
  • 13.14 Neurocog Trials, Inc.
  • 13.15 Posit Science

List of Tables

  • Table 1 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Computerized Cognitive Assessment Tools (2024-2032) ($MN)
  • Table 4 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Web-based platforms (2024-2032) ($MN)
  • Table 5 Global Personalized Neurocognitive Assessment Tools Market Outlook, By App-based platforms (2024-2032) ($MN)
  • Table 6 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Traditional Paper-and-Pencil Assessment Tools (2024-2032) ($MN)
  • Table 7 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 8 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Deployment Type (2024-2032) ($MN)
  • Table 9 Global Personalized Neurocognitive Assessment Tools Market Outlook, By On-premise (2024-2032) ($MN)
  • Table 10 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Cloud-based (2024-2032) ($MN)
  • Table 11 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Cognitive Functionality (2024-2032) ($MN)
  • Table 12 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Memory (2024-2032) ($MN)
  • Table 13 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Attention (2024-2032) ($MN)
  • Table 14 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Executive Function (2024-2032) ($MN)
  • Table 15 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Language Skills (2024-2032) ($MN)
  • Table 16 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Processing Speed (2024-2032) ($MN)
  • Table 17 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Visuospatial Skills (2024-2032) ($MN)
  • Table 18 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Technology (2024-2032) ($MN)
  • Table 19 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Artificial Intelligence (AI) Enabled Tools (2024-2032) ($MN)
  • Table 20 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Virtual Reality (VR) / Augmented Reality (AR) Tools (2024-2032) ($MN)
  • Table 21 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Cloud-Based Platforms (2024-2032) ($MN)
  • Table 22 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Mobile Applications (2024-2032) ($MN)
  • Table 23 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Mode of Administration (2024-2032) ($MN)
  • Table 24 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Self-administered (2024-2032) ($MN)
  • Table 25 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Clinician-administered (2024-2032) ($MN)
  • Table 26 Global Personalized Neurocognitive Assessment Tools Market Outlook, By End User (2024-2032) ($MN)
  • Table 27 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 28 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
  • Table 29 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Home Healthcare (2024-2032) ($MN)
  • Table 30 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 31 Global Personalized Neurocognitive Assessment Tools Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.